Related Experiment Video
Updated: Mar 1, 2026

04:22
Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
Published on: May 30, 2025
1.1K
Defining premature ejaculation for experimental and clinical investigations
D L Rowland1, S E Cooper, M Schneider
1Department of Psychology, Valparaiso University, Valparaiso, Indiana 46383, USA. David.Rowland@valpo.edu
Archives of Sexual Behavior
|May 2, 2001
Summary
Diverse definitions of premature ejaculation (PE) hinder research progress. This study proposes a unified model for defining PE groups to standardize future research and improve understanding of this condition.
Area of Science:
- Sexual Health Research
- Urology
- Psychology
Background:
- Premature ejaculation (PE) research is hampered by inconsistent definitions and classification criteria.
- A lack of standardized methods limits progress in understanding PE subtypes and etiologies.
Purpose of the Study:
- To summarize existing research on premature ejaculation definitions and methodologies.
- To identify patterns and compare definitions across different study types.
- To propose a common model for defining PE groups to guide future research.
Main Methods:
- A systematic survey of two bibliographic databases identified 45 studies defining or describing PE groups.
- Data extracted included participant characteristics, recruitment, PE subtypes, classification criteria, partner information, and inclusion/exclusion criteria.
- Analysis focused on identifying commonalities, differences, and trends in PE definition methodologies.
Main Results:
- Over 50% of studies lacked specific criteria or relied on self-identification for PE classification.
- Quantifiable behavioral criteria, primarily ejaculatory latency, were used in 49% of studies.
- Ejaculatory latency was more common in sexual response studies, while penile thrust count appeared in pre-1989 research.
Conclusions:
- The absence of universally accepted PE criteria and subtype identification impedes research and treatment development.
- A proposed flowchart, based on 40 years of research, offers a standardized approach to characterizing PE.
- Standardization is crucial for advancing the field of premature ejaculation research and therapeutic interventions.
Related Concept Videos
Urodynamic Studies: Uroflowmetry
5.9K
Uroflowmetry is a non-invasive urodynamic test designed to measure various aspects of urination, including volume, flow rate, and the time to void. This test is crucial for diagnosing and assessing conditions such as bladder outlet obstruction, bladder dysfunction, incomplete bladder emptying, incontinence, and urinary tract blockages caused by benign prostatic hyperplasia (BPH) and urethral strictures.Pre-Test Instructions:Before a uroflowmetry test, patients are typically advised to drink...
5.9K
Male Sexual Response: Erection & Ejaculation
24.1K
Sexual stimulation can take various forms, such as physical touch and visual or auditory cues. When this happens, the parasympathetic reflex in the sacral portion of the spinal cord is activated. This reflex stimulates the release of nitric oxide (NO), which then dilates the arterioles in the penis, increasing blood flow to the erectile tissues - the corpora cavernosa and corpus spongiosum.
The blood filling the erectile tissues compresses the veins, which helps to prevent blood from leaving...
The blood filling the erectile tissues compresses the veins, which helps to prevent blood from leaving...
24.1K
Preclinical Development: Overview
6.2K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
6.2K
Clinical Trials
11.0K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
11.0K
Clinical Trials: Overview
5.2K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.2K

